John Menditto | VP, IR & Corporate Communications |
David Mazzo | President, CEO & Director |
Joseph Talamo | CFO & SVP |
Douglas Losordo | EVP, Global Head, R&D & Chief Medical Officer |
Emanuela Branchetti | H.C. Wainwright & Co. |
Peter Enderlin | MAZ Capital Advisors |
Hello, and welcome to the Caladrius Biosciences First Quarter 2020 Financial Results and Business Update Conference Call. [Operator Instructions].
As a reminder, this call is being recorded today, Thursday, May 7, 2020.
I will now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communications at Caladrius. Please go ahead, sir.